Oral pill trial offers new hope for controlling rare blood disease
NCT ID NCT07470762
Summary
This study is testing a new oral medication called HS-10542 for adults with paroxysmal nocturnal hemoglobinuria (PNH), a rare disease where the immune system destroys red blood cells. The goal is to see if the pill can safely control the disease and improve blood counts, especially for patients who aren't getting enough benefit from their current standard injections. The trial will first find the best dose and then expand to see how well it works.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAROXYSMAL NOCTURNAL HEMOGLOBINURIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The First Affiliated Hospital，Zhejiang University School of Medicine
RECRUITINGHangzhou, Zhejiang, 310000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.